相关实验视频
Updated: Jun 18, 2025

00:09
Radiosensitivity of Cancer Stem Cells in Lung Cancer Cell Lines
Published on: August 21, 2019
7.0K
在肺癌干细胞中,TIPRL通过CaMKK2-CaMK4-CREB反环激活来调节干细胞和存活率
In-Sung Song1, Yu-Jeong Jeong1, Jae Kwang Yun2
1Department of Biochemistry and Molecular Biology, Brain Korea 21 Project, Asan Medical Center, University of Ulsan College of Medicine, Seoul, 138-736, Republic of Korea.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)
|July 30, 2024
概括
向TIPRL和CaMKK2信号可以克服耐药性,并通过抑制癌症干细胞存活和促进细胞死亡来减少肺癌转移.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 癌症干细胞 (CSCs) 驱动肺癌复发和转移,这给治疗带来了重大挑战.
- 确定具体的CSC目标对于开发有效的向治疗非常重要.
研究的目的:
- 研究TOR信号通路调节器类 (TIPRL) 在肺中枢肺细胞中的作用.
- 阐明TIPRL促进肺癌进展的分子机制.
- 评估TIPRL和CaMKK2信号轴作为潜在的治疗点.
主要方法:
- 研究了TIPRL表达及其与肺CSC中的CaMKK2的相互作用.
- 分析了CaMKK2-CaMK4-CREB信号通路的激活.
- 评估了TIPRL耗尽对CSC对阿法替尼布和体内转移的敏感性的影响.
- 确定了CREB和TIPRL之间的监管关系.
主要成果:
- 上调的TIPRL维持了CaMKK2通路的激活,维持了肺中枢细胞干和生存.
- CaMKK2-CaMK4-CREB轴的激活导致CREB的酸化和下游基因表达 (Bcl2,HMG20A).
- 耗尽TIPRL使肺中枢细胞对阿法替尼布敏感,并减少转移;CREB积极调节TIPRL转录,形成一个反循环.
结论:
- 由CREB-TIPRL正反循环驱动的TIPRL-CaMKK2信号轴促进肺癌瘤发生,干和生存.
- 针对TIPRL和CaMKK2通路提供了一种有希望的策略,以克服耐药性和减少肺癌转移.
相关概念视频
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Regulation of Angiogenesis and Blood Supply
2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
Cancer Stem Cells and Tumor Maintenance
4.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.9K
PI3K/mTOR/AKT Signaling Pathway
3.5K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.5K
Role Of Notch Signalling In Intestinal Stem Cell Renewal
2.1K
Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.1K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K

